Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
PON2 has been evaluated as a susceptibility locus for amyotrophic lateral sclerosis (ALS) through case–control and sequencing studies. A haplotype at the C-terminal portion of PON2, including the Cys311Ser variant, showed significant association with ALS in France (480 cases, 475 controls; p = 0.0075), Quebec (159 cases, 95 controls; p = 0.026), and combined cohorts (1,197 cases, 1,076 controls; p = 1.69 × 10⁻⁶) (PMID:18695162). Targeted sequencing identified rare coding variants, including c.286del (p.Arg96LeufsTer) in familial and sporadic cases (PMID:20582942) and c.677A>G (p.Asn226Ser) in an Indian cohort (1/154 cases; 5.36% of sALS; PMID:31432357). However, a large meta-analysis of 4,037 ALS cases and 4,609 controls found no significant association for the PON2 intronic marker rs10487132 (OR 1.08, p = 0.35) after correction (PMID:19321847). No familial segregation data are available.
Functional studies directly linking PON2 to ALS pathogenesis are lacking. PON2 deficiency in mice leads to impaired motor coordination on rotarod testing, increased oxidative stress, and region-specific transcriptomic changes in brain regions (PMID:34216730), consistent with a role in neuronal resilience. The absence of replication across independent case–control studies and limited mechanistic data yield a constrained assessment of clinical validity and functional impact.
Key take-home: PON2 variants may modulate ALS risk, but current genetic and functional data are insufficient for definitive clinical interpretation.
Gene–Disease AssociationLimitedOne strong haplotype association in three populations ([PMID:18695162]) but non-replication in a large meta-analysis ([PMID:19321847]) and few rare variants identified Genetic EvidenceLimitedSingle case–control haplotype study with 1,197 cases/1,076 controls ([PMID:18695162]) and isolated rare variants; lack of segregation Functional EvidenceLimitedPON2-deficient mice show motor deficits and oxidative stress ([PMID:34216730]) but no ALS-specific functional model |